期刊
ANALYTICA CHIMICA ACTA
卷 1141, 期 -, 页码 1-12出版社
ELSEVIER
DOI: 10.1016/j.aca.2020.10.032
关键词
Sildenafil; Monoclonal antibody; Gold nanoparticle; Immunochromatographic assay
资金
- National Key Research and Development of China [2018YFC1602904]
- National Natural Science Foundation of China [31871887]
- Science and Technology Planning Project of Guangzhou [201704020082]
- Science and Technology Planning Project of the Guangxi [AB18126048]
- Guangdong Basic and Applied Basic Research Foundation [2019B1515210025, 2020A1515011238, 2018B030314005]
- Key Scientific Research Projects of Guangdong Provincial Universities and Colleges [2018KZDXM011]
- Graduate Student Overseas Study Program of South China Agricultural University [2019LHPY003]
A gold nanoparticle-based immunochromatographic assay was developed for simultaneous detection of sildenafil and its analogues, with qualitative and quantitative analysis capabilities in a rapid manner.
In the last few years, sildenafil and its analogues have emerged as an illegal ingredient in health food and products, causing illness and death. To address this problem, herein, a gold nanoparticle-based immunochromatographic assay for simultaneous detection sildenafil and its analogues was developed by using just one monoclonal antibody. This method can realize qualitative and quantitative analysis of sildenafil and its analogues with a detection range (IC20-IC80) of 0.12-28.05 ng mL(-1), the IC50 was 0.31 -8.45 ng mL(-1) and the cut-off value was 5.0-80.0 ng mL(-1). Meanwhile, this method could also accomplish semi-quantitative analysis of vardenafil with a cut-off value of 0.625 ng mL(-1) . The detection can be finished in 6 min and showed no cross-reactivity with avanafil and tadalafil. The recoveries of spiked samples ranged from 70.5 to 118.9% with a coefficient variation less than 15%, which confirmed the assay was sensitive, accurate and adapted to the rapid determination of sildenafil and its analogues. (C) 2020 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据